FDA NDC Directory · JSON-LD · Markdown

QUESTRAN

NDC 49884-937 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Generic nameCholestyramine
Labeler / ManufacturerEndo USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA077203
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/5g)
Marketing started20030724
Package count1

External sources

Source: openFDA. Public-domain (CC0).